Comparative Pharmacology
Head-to-head clinical analysis: DECA DURABOLIN versus DROLBAN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DECA DURABOLIN versus DROLBAN.
DECA-DURABOLIN vs DROLBAN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Nandrolone decanoate is an anabolic steroid that binds to androgen receptors, increasing protein synthesis and promoting muscle growth. It also stimulates erythropoietin production, increasing red blood cell mass.
Cannabinoid receptor type 1 (CB1) agonist; inhibits adenylate cyclase and modulates calcium and potassium channels in presynaptic neurons, reducing neurotransmitter release.
Intramuscular injection of 100-200 mg every 1-3 weeks for anabolic effects; for replacement therapy, 50-100 mg every 2-4 weeks.
50 mg orally twice daily or 50 mg intramuscularly/intravenously every 8 hours.
None Documented
None Documented
Terminal half-life of nandrolone decanoate is 4.3 hours for the decanoate ester, but the active metabolite nandrolone has a prolonged half-life of 6-7 days due to slow release from intramuscular depot and enterohepatic recirculation; clinical effects persist for 3-4 weeks.
Terminal elimination half-life: 18-24 hours; clinical context: supports once-daily dosing, requires dose adjustment in renal impairment (CrCl <30 mL/min increase half-life by ~2-fold)
Primarily renal (90% as metabolites, 5% unchanged); fecal elimination accounts for <5%.
~70% renal (primarily as glucuronide conjugates, minor unchanged), ~30% biliary/fecal
Category C
Category C
Anabolic Steroid
Anabolic Steroid